---
title: "NCPC: Restructured Tetanus Vaccine (Escherichia coli) Clinical Trial Approved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240320337.md"
description: "According to the Zhitong Finance APP, NCPC announced that its subsidiary, North China Pharmaceutical Jintan Biotechnology Co., Ltd. (referred to as \"Jintan Company\"), has received the \"Drug Clinical Trial Approval Notice\" for the recombinant tetanus vaccine (Escherichia coli) approved by the National Medical Products Administration"
datetime: "2025-05-15T08:28:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240320337.md)
  - [en](https://longbridge.com/en/news/240320337.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240320337.md)
generator: "portal-rs"
---

# NCPC: Restructured Tetanus Vaccine (Escherichia coli) Clinical Trial Approved

According to the Zhitong Finance APP, NCPC (600812.SH) announced that its subsidiary, North China Pharmaceutical Jintan Biotechnology Co., Ltd. (referred to as "Jintan Company"), has received the "Drug Clinical Trial Approval Notice" for the recombinant tetanus vaccine (Escherichia coli) approved by the National Medical Products Administration

### Related Stocks

- [600812.CN](https://longbridge.com/en/quote/600812.CN.md)

## Related News & Research

- [Havas, linked to Louis Hachette director Yannick Bolloré, purchases EUR 5.31 million of Louis Hachette Group shares](https://longbridge.com/en/news/298621675.md)
- [CenTrio Selected as a Houston Business Journal Best Place to Work](https://longbridge.com/en/news/298618491.md)
- [Best Fashion Media Discloses Manager-Linked Share Subscription](https://longbridge.com/en/news/298556717.md)
- [Orogen Royalties acquires Serpent gold project in Nevada](https://longbridge.com/en/news/298589169.md)
- [Audius managing body member Wolfgang Wagner buys shares for EUR 1,890.50](https://longbridge.com/en/news/298272172.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**